Amanda B Summerfield, PA
Medical · Parkersburg, WVNPI 1144591355
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 266 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 28 manufacturers reported payments, led by AbbVie at 35.0% of the total. Reporting peaked in 2023 at $1,424 and has fallen 51.7% since, to $688 in 2025.
Across 266 payments — averaging $17.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Corium, LLC$601
- Ironshore Pharmaceuticals Inc.$349
- AstraZeneca$230
- Exact Sciences$218
- Merck$152
- plus $2K from 22 others
What the payments were for
- Food & beverage$4,702100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 94 | $1,643 |
| Corium, LLC | 37 | $601 |
| Ironshore Pharmaceuticals Inc. | 19 | $349 |
| AstraZeneca | 10 | $230 |
| Exact Sciences | 9 | $218 |
| Merck | 8 | $152 |
| Lilly USA, LLC | 8 | $132 |
| Biohaven Pharmaceutical Holding Company Ltd. | 8 | $129 |
| Biohaven Pharmaceuticals, Inc. | 9 | $128 |
| Sumitomo Pharma America, Inc. | 6 | $124 |
| Pfizer | 7 | $118 |
| Novo Nordisk | 7 | $110 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $102 |
| GSK | 5 | $98 |
| Sanofi-aventis U.S. LLC | 5 | $82 |
| Xeris Pharmaceuticals, Inc. | 4 | $75 |
| Sanofi Pasteur Inc. | 3 | $66 |
| Boehringer Ingelheim | 4 | $64 |
| Avanir Pharmaceuticals, Inc. | 3 | $57 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $53 |
| Neos Therapeutics, LP | 3 | $49 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Collegium Pharmaceutical, Inc. | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Novartis | 1 | $17 |
| Johnson & Johnson | 1 | $17 |
| Astellas Pharma US Inc | 1 | $13 |
| Aytu Biopharma, Inc. | 1 | $11 |
How this compares
$4,702 in reported general payments places this provider in the 85th percentile of 233 medical providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 12 | $11,809 |
| EliquisApixaban | 13 | $7,531 |
| XareltoRivaroxaban | 11 | $6,305 |
| SymbicortBudesonide/Formoterol Fumarate | 13 | $3,132 |
| Escitalopram Oxalate | 54 | $515 |
| Omeprazole | 49 | $499 |
| Atorvastatin Calcium | 63 | $453 |
| Levothyroxine Sodium | 30 | $396 |
| Amlodipine Besylate | 59 | $336 |
| Metoprolol Succinate | 28 | $317 |
| Azelastine Hcl | 16 | $308 |
| Rosuvastatin Calcium | 25 | $268 |
| Gabapentin | 19 | $234 |
| Bupropion XlBupropion Hcl | 13 | $167 |
| Montelukast Sodium | 17 | $167 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity | $132 | $11,80912 claims |
| PfizerEliquis | $118 | $7,53113 claims |
| Johnson & JohnsonXarelto | $17 | $6,30511 claims |
| AstraZenecaSymbicort | $230 | $3,13213 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 233 medical providers in West Virginia.
Other medical in Parkersburg
- Katherine BoggsSouth Charleston$46K
- Lowell LarewMorgantown$31K
- Katie CarpenterSouth Charleston$26K
- Lauren DillonBeckley$18K
- Angela HagerFarmington$16K
- Brandon CaragCharleston$16K
- Scott EthridgeCharleston$16K
- Kellie HanselSouth Charleston$12K
- Matthew MaynardElkins$10K
- Mohammad YousafCharleston$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.